Press release
Innovative Products Drive Market Advancements In The Neuralgia Treatment Industry Trend: A Crucial Influence on the Neuralgia Treatment Market's Transformation in 2025
Neuralgia Treatment Market Growth
The neuralgia treatment market has demonstrated strong growth in recent years. It is anticipated to grow from $2.3 billion in 2024 to $2.44 billion in 2025, at a CAGR of 6.0%. The market's historical growth has been supported by the increasing prevalence of neuralgia, growing awareness of neuropathic pain, the rising incidence of chronic pain conditions, higher disposable incomes, and government initiatives.
The neuralgia treatment market is projected to grow steadily, reaching $3.13 billion by 2029 at a CAGR of 6.4%. Growth is driven by an aging population, emerging therapies, rising diabetes incidences, and increased healthcare spending. Trends include advancements in pain management, innovative products, digital health integration, and new drug delivery systems.
What Factors Are Fueling Growth in the Neuralgia Treatment Market?
The increasing prevalence of chronic illnesses, including diabetes, is anticipated to drive the expansion of the neuralgia treatment market. Chronic diseases are long-lasting conditions that typically persist for a year or more, requiring ongoing medical attention, limiting daily activities, or both. Diabetes is a persistent metabolic disorder marked by elevated blood sugar levels. Neuralgia treatment is essential for managing diabetic neuropathy, a form of nerve damage that affects individuals with diabetes. For example, in September 2023, the World Health Organization, a Switzerland-based UN agency, reported that non-communicable diseases (NCDs) or chronic illnesses account for 74% of global deaths annually, amounting to 41 million fatalities. Consequently, the rising prevalence of chronic diseases like diabetes is fueling the growth of the neuralgia treatment market.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12921&type=smp
Which Leading Companies Are Shaping the Growth of the Neuralgia Treatment Market?
Major companies operating in the neuralgia treatment market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Bayer AG, Novartis AG, Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott Laboratories, GlaxoSmithKline PLC, Eli Lilly and Company, Gilead Sciences Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Astellas Pharma Inc., Biogen Inc., Daiichi Sankyo Company Limited, Boehringer Ingelheim International GmbH, Sun Pharmaceutical Industries Limited, Horizon Therapeutics, Purdue Pharma, Dr. Reddy's Laboratories, Cipla Limited, Hikma Pharmaceuticals PLC, Zydus Lifesciences Ltd., Lupin Limited, Mallinckrodt Pharmaceuticals, Glenmark Pharmaceuticals, Tonix Pharmaceuticals.
What Are the Major Trends Shaping the Neuralgia Treatment Market?
Leading businesses in the neuralgia treatment market are focused on launching innovative products to sustain their industry presence. For example, in April 2023, GlaxoSmithKline Pharmaceuticals Ltd., an India-based pharmaceutical company, introduced Shingrix, the world's first non-live recombinant subunit vaccine. Designed to prevent shingles and post-herpetic neuralgia in adults aged 50 and above, this vaccine is administered in two doses intramuscularly. Shingrix combines the antigen glycoprotein E with the AS01B adjuvant system, producing a strong and long-lasting immune response. Clinical trials have demonstrated its 97% efficacy in preventing shingles and post-herpetic neuralgia.
What Are the Key Segments of the Neuralgia Treatment Market?
The neuralgia treatment market covered in this report is segmented -
1) By Treatment: Drug Based, Surgeries
2) By Indication: Diabetic Neuropathy, Intercostal Neuralgia, Occipital Neuralgia, Peripheral Neuralgia, Postherpetic Neuralgia
3) By Distribution channels: Drug Stores, Hospital Pharmacies, Online Pharmacies, Retail Pharmacies
4) By End-Use: Hospitals And Clinics, Ambulatory Surgery Centers, Other End-Users
Subsegments:
1) By Drug Based: Anticonvulsants, Antidepressants, Opioids, Topical Treatments, Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
2) By Surgeries: Nerve Block Procedures, Decompression Surgery, Neurectomy, Spinal Cord Stimulation
Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/neuralgia-treatment-global-market-report
Which Region Dominates the Neuralgia Treatment Market?
North America was the largest region in the neuralgia treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in neuralgia treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
What Is Covered In The Neuralgia Treatment Global Market Report?
- Market Size Analysis: Analyze the Neuralgia Treatment Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Neuralgia Treatment Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Neuralgia Treatment Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Neuralgia Treatment Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12921
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Innovative Products Drive Market Advancements In The Neuralgia Treatment Industry Trend: A Crucial Influence on the Neuralgia Treatment Market's Transformation in 2025 here
News-ID: 3853009 • Views: …
More Releases from The Business Research Company
Chemical Catalyst Market Growth to be Driven by Emerging Trends | $50.76 Billion …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What is the Projected Market Size of the Chemical Catalyst Industry?
The market for chemical catalysts has been experiencing consistent growth in the past few years. The market, which is expected to reach $39.75 billion in 2024, is predicted to further escalate to $41.73 billion in 2025, growing at a CAGR…
Luminous Paint Market Expansion Outlook: $23.42 Billion in 2029
Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments.
What Is the Projected CAGR for the Luminous Paint Market from 2024 to 2025?
Over the past few years, the luminous paint market has experienced significant growth. This market's size is projected to increase from $15.38 billion in 2024 to $16.73 billion in 2025, with a compound annual growth rate (CAGR) of…
Bio-based Materials Industry Growth Outlook: 21.7% CAGR and $104.16 Billion by 2 …
Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments.
What Is the Long-Term Growth Forecast for the Bio-based Materials Market Size 2025?
In the past few years, the size of the bio-based materials market has experienced significant growth. It is anticipated that the market, which was worth $38.16 billion in 2024, will increase to $47.42 billion in 2025, marking a compound…
Heat Transfer Fluids Market to Record 6% CAGR Growth Through 2029 | Global Analy …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Heat Transfer Fluids Market Outlook: How is the Market Expected to Grow by 2025?
The market size for heat transfer fluids has seen robust growth in the recent past. The figure is projected to rise from $4.01 billion in 2024 and reach $4.23 billion in 2025, with a compound annual…
More Releases for Neuralgia
Postherpetic Neuralgia Market Trends, Treatments, and Growth Opportunities
Postherpetic neuralgia (PHN) is a debilitating complication of shingles (herpes zoster), causing chronic nerve pain that significantly affects patients' quality of life. The Postherpetic Neuralgia Market has gained substantial attention in recent years, as healthcare providers, pharmaceutical companies, and research organizations work toward effective pain management solutions. The growing prevalence of shingles, aging populations, and advances in therapeutic interventions underscore the critical need for innovative PHN treatments.
Download Full PDF Sample…
Postherpetic Neuralgia Treatment Drugs, Pipeline Insights Report 2024
DelveInsight's, "Postherpetic Neuralgia Pipeline Insight 2024" report provides comprehensive insights about 12+ companies and 12+ pipeline drugs in Postherpetic Neuralgia pipeline landscape. It covers the Postherpetic Neuralgia pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Discover the latest drugs and treatment options in…
Postherpetic Neuralgia Pipeline Featuring 12+ Companies Expected to Change the P …
"The neuralgia is excruciating with superimposed lancinating paresthesias. Pain may be constant or intermittent, aggravated by minor stimulus (allodynia) such as heat or touch, and is worse at night. The agony of pain leads to insomnia, anorexia, and changes in mood (severe depression)"
The drug is described in detail in the Postherpetic Neuralgia pipeline report, along with its mechanism of action, Postherpetic Neuralgia clinical trials, Postherpetic Neuralgia NDA approvals (if any),…
Trigeminal Neuralgia Treatment Market Size, Trigeminal Neuralgia Treatment Marke …
Trigeminal Neuralgia Treatment Market Dynamics are clarified by an in-depth review of facts on current and emerging trends. To understand a resource, the paper uses Porter's five forces to examine the importance of numerous qualities such as understanding of suppliers and customers, dangers provided by various agents, competitive strength, and promising new businesses. precious. Furthermore, the study covers numerous firms' Trigeminal Neuralgia Treatment research data, benefit, gross margin, worldwide market…
Trigeminal Neuralgia - Drug Pipeline Landscape, 2022
Trigeminal Neuralgia (TN), also known as tic douloureux, is a condition that causes painful sensations similar to an electric shock on one side of the face. The pain typically involves the lower face and jaw, although sometimes it affects the area around the nose and above the eye.
There are two types of TN primary and secondary. Primary trigeminal Neuralgia has been linked to the compression of the nerve. Trigeminal Neuralgia…
Trigeminal Neuralgia Treatment Market Opportunity Analysis, to 2026
Trigeminal neuralgia (TN), also known as tic douloureux, is a chronic pain disorder that affects the fifth cranial or trigeminal nerve. It causes inflammatory conditions due to systemic diseases including Lyme disease, sarcoidosis, and multiple sclerosis. There is also an association with collagen vascular diseases including systemic lupus erythematosus and scleroderma. The condition is treated on an outpatient basis, except till neurosurgical intervention is required. Its management must be customized…
